STEM Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Minnesota.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 13, 2025

November 13, 2025

RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update

GlobeNewswire

November 13, 2025

Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates

GlobeNewswire

November 13, 2025

Hyperion DeFi Reports Third Quarter 2025 Financial Results with Record Net Income of $6.6 Million

GlobeNewswire

November 13, 2025

Fluent Announces Third Quarter 2025 Financial Results; Commerce Media Solutions Annual Revenue Run Rate Exceeds $85 Million and Represents 40% of Consolidated Revenue

GlobeNewswire

November 13, 2025

Amneal Receives U.S. FDA Approval for Iohexol Injection

GlobeNewswire

November 13, 2025

Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

November 13, 2025

Elicio Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

GlobeNewswire

November 13, 2025

TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility

GlobeNewswire

November 13, 2025

Relmada Therapeutics Reports Third Quarter 2025 Financial Results and Provides Key Clinical, Regulatory, and Corporate Updates

GlobeNewswire

November 13, 2025

Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

November 13, 2025

ヌマブ・セラピューティクス (Numab Therapeutics) および科研製薬 (Kaken Pharmaceutical)、炎症性腸疾患 (IBD) における多特異性抗体NM81のライセンスおよび共同開発契約を発表

GlobeNewswire

November 13, 2025

Why Hiring Professional Painters from Berger Paints is the Smartest Choice This Festive Season

GlobeNewswire

November 13, 2025

GPT Invest Unveiled: How The GPT Invest Platform Is Delivering Real Results to Global Investors

GlobeNewswire

November 13, 2025

Free Spins No Deposit Casino - Get $200 No Deposit Bonus 200 Free Spins Real Money

GlobeNewswire

November 13, 2025

Herpafend Unveiled: How This Herpafend Supplement Becomes the Go-To Natural Solution for Cold Sore and Herpes Relief

GlobeNewswire

November 13, 2025

Quiet Lab Mouthpiece Launches: A Scientific Breakthrough in QuietLab Anti-Snoring Devices and Sleep Health Innovation

GlobeNewswire

November 13, 2025

Coupons.com Launches Cashback Feature and Browser Extension Ahead of Black Friday

GlobeNewswire

November 13, 2025

OnStation and Trimble: Live Digital Stationing Meets Location Precision

GlobeNewswire

November 13, 2025

Turning Vision Into Value: Cie Portfolio Win as Nativo Is Acquired for $120M

GlobeNewswire

November 13, 2025

60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results

GlobeNewswire